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ANTAGONISM OF KETAMINE-DIAZEPAM ANAESTHESIA BY
4-AMINOPYRIDINE IN HUMAN VOLUNTEERS
S. AGOSTON, P. J. SALT, W. ERDMANN, T. HILKEMEIJER, A. BENCINI AND D. LANGREHR
SUMMARY
Five healthy human volunteers were anaesthetized on two separate occasions, 1 week apart, using
a standard diazepam-ketamine induction followed by an infusion of ketamine for 1 h. Ten minutes
after stopping the infusion, either 4-aminopyridine 0.3 mgkg"1 in saline or the same volume of
saline alone was administered i.v. It was concluded that 4-aminopyridine enhanced dramatically
the rate of recovery of the subjects to full consciousness and normal motor co-ordination when
compared with the saline controls.
The compound 4-aminopyridine (4-AP) is of interest
to anaesthetists because it is a potent antagonist of
the neuromuscular blocking actions of non-depolar-
izing myoneural blocking drugs (Lemeignan and
Lechat, 1967; Paskov, Stojanov and Micov, 1973;
Bowman, Harvey and Marshall, 1977; Harvey and
Marshall, 1977). In fact, it has been used clinically
in Bulgaria as an antagonist to tubocurarine for
several years (Paskov, Stojanov and Micov, 1973;
Stojanov et al., 1976).
In contrast to neostigmine, it is free from anti-
cholinesterase activity and its mechanism of action
appears to be pre-junctional (Lundh, Leander and
Thesleff, 1977). It enhances the release of transmitter
from the motor nerve terminals (Lundh and Thes-
leflF, 1977; Molgo, Lemeignan and Lechat, 1977;
Vizi, van Dijk and Foldes, 1977). However, this pre-
junctional action appears to be a general one affecting
other nerve terminals also. For instance, in the peri-
phery, 4-AP has been shown to potentiate the effects
of adrenergjc stimulation in the rabbit vas deferens
(Johns et al., 1976) and its action here was considered
to be presynaptic, resulting in an increased release
of the sympathetic transmitter in response to nerve
stimulation.
There is an increasing body of experimental evid-
ence concerning the c.n.s. effects of 4-AP, suggesting
that it crosses the blood-brain barrier freely. The
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central actions are thought to be mediated by a pre-
synaptic mechanism similar to that seen in the peri-
phery, and are not necessarily restricted to effects
upon any particular type of synapse or transmitter.
Thus, 4-AP has been shown to facilitate transmission
in excitatory and inhibitory pathways in the spinal
cord of the cat (Lemeignan, 1972, 1973; Jankowska
et al., 1977) and the sixth ganglion of the cockroach
(Hue et al., 1976). Furthermore, Nicholson and col-
leagues (1976) have shown that 4-AP can alter extra-
cellular calcium and potassium concentrations in the
cat cerebellum and may thereby alter the excitability
of the cerebellar neurones. 4-AP has also been found
to alter the turnover of monoamines in the central
nervous system of rats (Anden and Leander, 1979).
Finally, a central effect of 4-AP which has a direct
relevance to its use in anaesthetic practice has been
noted in the cat, namely, stimulation of respiratory
drive as judged by phrenic nerve activity (See, Folger-
ing and Schlafke, 1978).
Because it was observed, in experiments designed
to investigate the antagonistic effect of 4-AP on tubo-
curarine-induced neuromuscular block in monkeys
anaesthetized with high doses of ketamine, that 4-AP
had a definite analeptic effect, even during an infu-
sion of ketamine (S. Agoston, unpublished observa-
tion), we decided to look for interactions between
4-AP and ketamine. Healthy human volunteers were
given a ketamine-diazepam anaesthetic and the effects
of 4-AP upon the subsequent rate of recovery from
this anaesthetic were monitored.
METHODS
Five healthy anaesthetists were subjected on two
occasions, at least 1 week apart, to a ketamine-diaz-
epam anaesthetic lasting 1 h. Following an injection
© Macmillan Journals Ltd 1980
368 BRITISH JOURNAL OF ANAESTHESIA
of atropine 0.5 mg i.v., anaesthesia was induced in
each subject with a bolus of diazepam 0.2 mg kg"1 i.v.
and ketamine 2.0 mg kg"1 i.v. An i.v. infusion of
saline containing ketamine 1 mg ml"1 was started.
During the subsequent 60 min ketamine 1 mg kg"1
was infused so that each volunteer received in total
ketamine 3 mg kg"1 during 1 h. Ten minutes after
stopping the infusion of ketamine either 4-AP 0.3
mg kg"1 or the same volume of saline was adminis-
tered i.v. Instead of measuring the "sleep time" we
decided to challenge each volunteer with a battery of
tests continuously after the injection of the 4-AP or
the saline alone. These tests were chosen in order to
obtain information about the graded return to norm-
ality of such higher cerebral functions as logical
thought, recall, short- and long-term memory and
general physical co-ordination. These tests are sum-
marized in table I and consist of repeated challenging
TABLE I. Time required for the successful completion of tests

























with simple mental arithmetic of increasing difficulty
as the level of consciousness increased, asking the
subject to read a simple sentence from a book and to
recall this 15 s later, remembering dates such as his
wife's birthday, the use of a calculator to perform
simple arithmetic and finally the return to a fully
ambulant state with no motor or sensory deficits.
Diazepam was included in this regime in order to
minimize the cardiovascular side-effects of the keta-
mine and allow amnesia of any undesirable halluci-
natory experiences during the period of "dissociative
anaesthesia" produced by the ketamine. Furthermore,
the anaesthetic sequence used was similar to that
utilized in clinical practice and it is hoped to
extend this study to include patients receiving a
comparable diazepam-ketamine anaesthetic.
RESULTS
The rate of recovery from the ketamine-diazepam
anaesthesia was improved greatly on those occasions
when the subjects received 4-AP, as judged by the
time needed to perform the various tests (table I).
Statistical analysis of the results (paired Student's
t test) showed a significant difference in the results
obtained with and without 4-AP treatment in every
test used. Subjective experiences of the recovery
period were the same for all volunteers. All the sub-
jects wakened suddenly, all senses returning simul-
taneously, when they received 4-AP, whereas when
saline was administered the subjects drifted slowly
into a state of consciousness, in some cases hearing
the voices of the investigators before they became
aware of them visually.
The only side-effects of 4-AP noted were a tingling
sensation around the lips and in one case a "vibrating
feeling" along the length of the arm where the injec-
tion site was located. No ketamine-induced halluci-
nations were experienced with or without 4-AP.
DISCUSSION
The results show clearly that 4-AP increased the
rate of recovery of the subjects from the diazepam-
ketamine anaesthesia as judged by the simple tests
used compared with the recovery rate when saline
was injected. The dose of 4-AP used (0.3 mg kg"1),
was relatively small and was roughly the same as that
which has been used to antagonize safely the effects
of tubocurarine and pancuronium in man (Stojanov
et al., 1976; Miller et al., 1979). These results maj
find a clinical use in the possible administration o:
4-AP as a means of decreasing the sometimes pro-
longed recovery time of patients after a ketamine
anaesthetic. This would alleviate not only the task of
the recovery room nursing staff and be of benefit to
the patient by returning him to a safe level of con-
sciousness more quickly, but could perhaps be of
especial use in conditions where a rapid recovery
from ketamine anaesthesia is essential, as in a major
disaster.
Several anaesthetic agents have been shown to
alter the turnover of acetycholine in the brain of
animals and the release of this putative central trans-
mitter may be influenced by 4-AP. For instance, it
is known that barbiturates inhibit the release ol
acetylcholine and cause its accumulation in the brair
(Giarman and Pepeu, 1962; Mitchell, 1963; Celesii
and Jasper, 1966; Crossland and Slater, 1968) and
Rao and co-workers (1977) have demonstrated an
antagonism between 4-AP and the anaesthetic effects
of pentobarbitone sodium and methohexitone in the
rat. Furthermore, the turnover of acetylcholine is
decreased in different brain areas of the rat after
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halothane, enfluranc or ketamine anaesthesia, each
agent causing a definite pattern of changes related to
the different cortical and subcortical sites of action
of these agents as determined from electrophysio-
logical studies (Ngai, Cheney and Finck, 1978).
Physostdgminc, the centrally-acting anticholinesterase,
has been used successfully in the past to antagonize
the effects of droperidol, benzodiazepines and other
centrally-acting drugs used in clinical anaesthesia
which are thought to act in part by interfering with
central cholinergic pathways (Bidwai, Cornelius and
Stanley, 1976; Hill, Stanley and Sentker, 1977). How-
ever, the indirect vagotonic action of physostigmine
represents a serious disadvantage to its use, necessi-
tating the additional administration of atropine,
which itself may antagonize its c.n.s. effects (Rumack,
1973). This problem does not exist with the adminis-
tration of 4-AP because of its lack of anticholin-
esterase activity. Indeed, Miller and colleagues (1979)
have emphasized the fact that it is not necessary to
give atropine when 4-AP is given in human subjects.
Folgering and his co-workers have actually found
evidence for antagonism of the central effects of 4-AP
by atropine in the cat (See, Folgering and SchlSfke,
1978; Folgering, Rutten and Agoston, 1979).
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ANTAGONISME DE L'ANESTHESIE A LA
KETAMINE ET AU DIAZEPAM PAR LA
4-AMINOPYRIDINE SUR DES VOLONTAIRES
RESUME
Cinq volontaires en bonne same ont etc anesthesies par
deux fois, a une semaine d'intervalle. L'induction a etc
provoqude d'une maniere standard par le diazepam et la
ketamine et celle-ci a etd suivie d'une infusion de ketamine
pendant 1 h. Dix minutes apres avoir arrete rinfusion, on a
administre par voie intraveineuse soit de la 4-aminopyridinc
(a raison de 0,3 mg kg"1) dans du serum physiologique,
soit le meme volume de serum physiologique seul. On en a
conclu que la 4-aminopyridine stimulait fortement le taux
de reprise de conscience des sujets jusqu'a la pleine prise de
conscience et a la coordination motrice normale, par
comparaison avec les temoins n'ayant recu que du serum
physiologique.




Fiinf gesunde Versuchspersonen wurden bei zwei
separaten Gelegenheiten, die eine Woche auseinanderlagen,
durch normale Ketamin-Diazepamverabreichung narko-
tisiert, gefolgt von einer einsrilndigen Ketamininfusion.
10 min nach der Infusion wurden entweder 4-Aminopyri-
din 0,3 mg kg"1 in Salzlosung, oder dieselbe Menge
Salzolsung allein intravenos verabreicht. Es ergab sich,
dass die Erholungsrate der Versuchspersonen bis zum
volligen Wiedererlangen des Bewusstseins und norma'er
motorischer Koordination durch 4-Aminopyridin ganz
wesentlich erhoht wurde, wenn man den Vergleich zur
Salzlosungs-Kontrollgruppe anstellte.





Se anestesiaron a cinco voluntaries humanos sanos en dos
oportunidades distintas, con intervalo de 1 semana, por
medio de la inducci6n de quetamina-diazepam normal
seguida por una infusiin de quetamina durante 1 h. Diez
minutos despues del termino de la infusi6n, se administr6
por via i.v. ya sea 0,3 mg kg"1 de aminopiridina-4 en
soluci6n salina ya sea el mismo volumen de solucidn
salina solo. Se llego a la conclusi6n de que la aminopiridina-4
realzo dramaticamente la velocidad de recuperaci6n de los
sujetos en lo que se refiere al pleno conocimiento y a la
coordinaci6n motora normal cuando se comparaban con
los controles que habian recibido soluci6n salina sola.
